Sara Mangsbo

8PUBLICATIONS
31CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Veterinary virologyPredictive and prognostic markersCellular immunologyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 05, 2024
A bispecific CD40 agonistic antibody allowing for antibody-peptide conjugate formation to enable cancer-specific peptide delivery, resulting in improved T proliferation and anti-tumor immunity in mice.

Aman Mebrahtu, Ida Laurén, Rosanne Veerman

|Apr 06, 2023
Epitopes Displayed in a Cyclic Peptide Scaffold Bind SARS-COV-2 Antibodies.

Camilla Eriksson, Sunithi Gunasekera, Taj Muhammad

|Mar 29, 2022
Long-term SARS-CoV-2-specific and cross-reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology.

Ida Laurén, Sebastian Havervall, Henry Ng

|Sep 30, 2021
An evaluation of a FluoroSpot assay as a diagnostic tool to determine SARS-CoV-2 specific T cell responses.

Sara M Mangsbo, Sebastian Havervall, Ida Laurén

|Aug 30, 2021
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.

Sebastian Havervall, Henry Ng, August Jernbom Falk

|Jul 07, 2021
Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine protein alterations.

Iliana K Kerzeli, Martin Lord, Milena Doroszko

Pageof 2

Frequent Collaborators

5 joint publications

Martin Lord

3 joint publications

August Jernbom Falk

3 joint publications

Ida Laurén

2 joint publications

Pierre Dönnes